MTHFD2 Enhances cMYC O-GlcNAcylation to Promote Sunitinib Resistance in Renal Cell Carcinoma

舒尼替尼 癌症研究 肾细胞癌 癌 内科学 医学
作者
Jinwen Liu,Gaowei Huang,Hao Lin,Rui Yang,Wenhao Zhan,Cheng Luo,Yukun Wu,Lingwu Chen,Xiaopeng Mao,Junxing Chen,Bin Huang
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:85 (6): 1113-1129 被引量:15
标识
DOI:10.1158/0008-5472.can-24-0050
摘要

Sunitinib is a first-line targeted therapy for patients with renal cell carcinoma (RCC), but resistance represents a significant obstacle to the treatment of advanced and metastatic RCC. Metabolic reprogramming is a characteristic of RCC, and changes in metabolic processes might contribute to resistance to sunitinib. In this study, we identified methylenetetrahydrofolate dehydrogenase 2 (MTHFD2), a mitochondrial enzyme involved in one-carbon metabolism, as a critical mediator of sunitinib resistance in RCC. MTHFD2 was elevated in sunitinib-resistant RCC cells, and loss of MTHDF2 conferred sensitivity to sunitinib. In patients, MTHFD2 was highly expressed in RCC and was associated with poor outcomes. Mechanistically, MTHFD2 stimulated UDP-N-acetylglucosamine (UDP-GlcNAc) biosynthesis and promoted cMYC O-GlcNAcylation by driving the folate cycle. O-GlcNAcylation enhanced cMYC stability and promoted MTHFD2 and cyclin D1 transcription. Targeting MTHFD2 or cyclin D1 sensitized tumor cells to sunitinib in vitro and in vivo. Consistently, development of a peptide drug capable of efficiently degrading MTHFD2 enabled reversal of sunitinib resistance in RCC. These findings identify a noncanonical metabolic function of MTHFD2 in cell signaling and response to therapy and reveal the interplay between one-carbon metabolism and sunitinib resistance in RCC. Targeting MTHFD2 could be an effective approach to overcome sunitinib resistance. Significance: MTHFD2 regulates cMYC O-GlcNAcylation to promote sunitinib resistance in renal cell carcinoma, highlighting the important role of one-carbon metabolism in sunitinib resistance and proposing therapeutic strategies to improve patient outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
空空发布了新的文献求助10
1秒前
沉默的从安完成签到,获得积分10
1秒前
星辰大海的应助被得得得采纳,获得10
1秒前
Ava的应助被潇湘学术采纳,获得10
1秒前
2秒前
2秒前
ww完成签到,获得积分10
2秒前
2秒前
犹豫白柏发布了新的文献求助10
2秒前
星1993发布了新的文献求助10
2秒前
2秒前
3秒前
3秒前
3秒前
3秒前
mark发布了新的文献求助10
3秒前
xxb完成签到,获得积分20
3秒前
DW的应助被liuzhanyu采纳,获得10
4秒前
白芨完成签到,获得积分10
5秒前
6秒前
水的三次方完成签到 ,获得积分10
6秒前
5845485678发布了新的文献求助10
6秒前
6秒前
SciGPT的应助被阿白采纳,获得10
6秒前
6秒前
asdfghjkl发布了新的文献求助10
6秒前
6秒前
7秒前
7秒前
7秒前
卷卷完成签到,获得积分10
7秒前
joe完成签到,获得积分10
7秒前
Teragous发布了新的文献求助10
7秒前
7秒前
无忧无虑发布了新的文献求助10
8秒前
8秒前
8秒前
04d的应助被未来可待采纳,获得20
8秒前
LIUJIAWEI发布了新的文献求助10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181155
求助须知:如何正确求助?哪些是违规求助? 9571140
关于积分的说明 21816740
捐赠科研通 7777528
什么是DOI,文献DOI怎么找? 3433436
关于科研通互助平台的介绍 2557664
邀请新用户注册赠送积分活动 2479482